Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1336 to 1350 of 2042 results for guidelines

  1. Rapid eye movement sleep behaviour disorder treatment:- What is the best first-line treatment for rapid eye movement sleep behaviour disorder (RBD) in people with Parkinson's disease?

    Any explanatory notes(if applicable) Why this is important:- The guideline committee highlighted the importance of minimising RBD, for...

    Research recommendation
    Published
    15 October 2018

  2. Embryo selection for single embryo transfer:- Further research is needed to improve embryo selection to facilitate single embryo transfers.

    embryo in order to maximise the chance of pregnancy. As detailed in the guideline, this practice has inherent risks, especially of...

    Research recommendation
    Published
    9 June 2015

  3. What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs) compared with a standard prophylactic dose for venous thromboembolism (VTE) prophylaxis in young people under 18 years with COVID-19?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    10 August 2021

  4. Monitoring for cystic-fibrosis-related diabetes:- What is the most effective strategy to detect diabetes in people with cystic fibrosis?

    annual testing for cystic-fibrosis-related diabetes is recommended in this guideline for people over 10 with cystic fibrosis, there is a...

    Research recommendation
    Published
    18 October 2018

  5. Does early review and referral to specialist palliative care services improve outcomes for adults with COVID-19 thought to be approaching the end of their life?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    10 August 2021

  6. Orthostatic hypotension treatment:- For people with Parkinson's disease, what is the most effective pharmacological treatment for orthostatic hypotension?Particular interventions and comparisons of interest are:- midodrine compared with fludrocortisone (primary comparison)- pyridostigmine- ephedrine - pseudoephedrine.

    Any explanatory notes(if applicable) Why this is important:- The guideline committee felt that orthostatic hypotension was an important...

    Research recommendation
    Published
    15 October 2018

  7. Mid-life interventions:- In the UK, which mid-life groups are currently at most risk of losing their independence or experiencing poor mental wellbeing in later life? And which interventions are most effective and cost effective in preparing these people for later life?

    help commissioners and providers to evaluate their services, and inform guideline updates. Source guidance details Comes from guidance

    Research recommendation
    Published
    25 January 2016

  8. Clean air zones:- How do different elements of a clean air zone interact to improve air quality and what is the overall effect on people's health?

    notes(if applicable) Why this is important:- At publication of this guideline, clean air zones were being introduced. These zones are...

    Research recommendation
    Published
    12 October 2018

  9. What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can be obtained when using a complete individual patient-based outcomes meta-analysis data set compared with using published outcomes data?

    Any explanatory notes(if applicable) Why this is important: This guideline development process uses published summary data from trials...

    Research recommendation
    Published
    9 June 2015

  10. Effective prevention of child abuse and neglect in the UK:- What interventions are effective and cost effective in the UK to prevent abuse and neglect of children and young people in families at risk of, or showing early signs of, abuse and neglect?

    applicable) Why this is important:- The evidence reviewed for this guideline on the effectiveness of interventions to prevent abuse and...

    Research recommendation
    Published
    18 October 2018

  11. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    10 August 2021

  12. What risk factors in people who are critically ill and have, or have had, COVID-19 as part of their acute illness are associated with developing COVID-19-associated pulmonary aspergillosis (CAPA)?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    17 December 2021

  13. Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (TA455)

    Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel) and ustekinumab (Stelara) for plaque psoriasis in children and young people.

    Technology appraisal guidance
    Published
    12 July 2017
    View recommendations

    Sections for TA455

  14. Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (TA406)

    Evidence-based recommendations on crizotinib (Xalkori) for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    28 September 2016
    View recommendations

    Sections for TA406

  15. AI technologies for detecting diabetic retinopathy (MIB265)

    NICE has developed a medtech innovation briefing (MIB) on AI technologies for detecting diabetic retinopathy .

    Medtech innovation briefing
    Published
    6 July 2021